OPTI — OptiBiotix Health Income Statement
0.000.00%
- £9.40m
- £8.10m
- £0.87m
- 46
- 18
- 18
- 14
Annual income statement for OptiBiotix Health, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.52 | 2.21 | 0.457 | 0.644 | 0.87 |
| Cost of Revenue | |||||
| Gross Profit | 0.88 | 1.12 | 0.244 | 0.32 | 0.331 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | -1.53 | 3.58 | -10.7 | 2.34 | 3.14 |
| Operating Profit | 3.05 | -1.37 | 11.1 | -1.7 | -2.27 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 5.71 | 6.18 | 2.44 | -2.04 | -1.87 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 5.8 | 6.26 | 2.59 | -2.04 | -1.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 5.8 | 6.26 | 2.59 | -2.04 | -1.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 5.8 | 6.26 | 2.59 | -2.04 | -1.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.032 | 0.066 | -0.067 | -0.023 | -0.018 |
| Dividends per Share |